Eli Lilly & Co. (NYSE: LLY) was raised to Buy from Hold at Jefferies on Wednesday, with analyst Akash Tewari ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change Hot List Upgrades

Eli Lilly & Co. (LLY) Completes Acquisition of DICE Therapeutics (DICE) August 9, 2023 9:03 AM Lilly Completes Acquisition of DICE TherapeuticsAugust 9, 2023 9:02 AM Eli Lilly (LLY) PT Raised to $617 at Morgan StanleyAugust 9, 2023 8:17 AM Eli Lilly (LLY) PT Raised to $600 at Truist SecuritiesAugust 9, 2023 7:20 AM Eli Lilly (LLY) PT Raised to $600 at JPMorganAugust 9, 2023 7:14 AM Eli Lilly (LLY) PT Raised to $470 at Goldman SachsAugust 9, 2023 5:57 AM Eli Lilly & Co. (LLY) option implied volatility flat as share prices at record highAugust 9, 2023 3:47 AM Eli Lilly (LLY) PT Raised to $590 at BarclaysAugust 9, 2023 3:19 AM Jefferies Upgrades Eli Lilly (LLY) to Buy, 'SELECT + Q2 Is a Home Run'August 9, 2023 2:39 AM Eli Lilly (LLY) PT Raised to $580 at Credit SuisseAugust 8, 2023 4:16 PM Form 10-Q ELI LILLY & Co For: Jun 30August 8, 2023 1:24 PM Eli Lilly, Chegg, AMC Entertainment rise premarket; UPS, Tesla fallAugust 8, 2023 8:18 AM